{"pmid":32402680,"title":"COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful.","text":["COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful.","J Cyst Fibros","Farfour, Eric","Picard, Clement","Beaumont, Laurence","Lesprit, Philippe","Ballester, Marie-Christine","Ackermann, Felix","Galliot, Richard","Colin de Verdiere, Sylvie","Cerf, Charles","Vasse, Marc","32402680"],"journal":"J Cyst Fibros","authors":["Farfour, Eric","Picard, Clement","Beaumont, Laurence","Lesprit, Philippe","Ballester, Marie-Christine","Ackermann, Felix","Galliot, Richard","Colin de Verdiere, Sylvie","Cerf, Charles","Vasse, Marc"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32402680","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jcf.2020.03.021","weight":0,"_version_":1666714494721589248,"score":9.490897,"similar":[{"pmid":32371562,"title":"Keep cystic fibrosis patients out of the hospital.","text":["Keep cystic fibrosis patients out of the hospital.","No specific data exists regarding management of patients with cystic fibrosis (CF) who are infected with COVID-19. Based on expert opinion, strategies for outpatient management include use of elexacaftor-tezacaftor-ivacaftor to reduce pulmonary exacerbations, telemedicine, adherence to prescribed regimens, prompt and aggressive treatment of CF exacerbations, and communication about COVID-19 with patients with CF. Strategies for inpatient management may vary due to special precautions to avoid the aerosolization of COVID-19 with the use of nebulized medications and other therapies.","Cleve Clin J Med","Dasenbrook, Elliot","32371562"],"abstract":["No specific data exists regarding management of patients with cystic fibrosis (CF) who are infected with COVID-19. Based on expert opinion, strategies for outpatient management include use of elexacaftor-tezacaftor-ivacaftor to reduce pulmonary exacerbations, telemedicine, adherence to prescribed regimens, prompt and aggressive treatment of CF exacerbations, and communication about COVID-19 with patients with CF. Strategies for inpatient management may vary due to special precautions to avoid the aerosolization of COVID-19 with the use of nebulized medications and other therapies."],"journal":"Cleve Clin J Med","authors":["Dasenbrook, Elliot"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371562","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3949/ccjm.87a.ccc005","e_drugs":["ivacaftor","elexacaftor","tezacaftor"],"topics":["Prevention","Treatment"],"weight":1,"_version_":1666138496397475840,"score":50.812355},{"pmid":32304639,"pmcid":"PMC7159857","title":"Impact of COVID-19 on people with cystic fibrosis.","text":["Impact of COVID-19 on people with cystic fibrosis.","Lancet Respir Med","Colombo, Carla","Burgel, Pierre-Regis","Gartner, Silvia","van Koningsbruggen-Rietschel, Silke","Naehrlich, Lutz","Sermet-Gaudelus, Isabelle","Southern, Kevin W","32304639"],"journal":"Lancet Respir Med","authors":["Colombo, Carla","Burgel, Pierre-Regis","Gartner, Silvia","van Koningsbruggen-Rietschel, Silke","Naehrlich, Lutz","Sermet-Gaudelus, Isabelle","Southern, Kevin W"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304639","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/S2213-2600(20)30177-6","topics":["Prevention"],"weight":1,"_version_":1666138491057078273,"score":48.555145},{"pmid":32303430,"pmcid":"PMC7152906","title":"Asymptomatic case of Covid-19 in an infant with cystic fibrosis.","text":["Asymptomatic case of Covid-19 in an infant with cystic fibrosis.","J Cyst Fibros","Poli, Piercarlo","Timpano, Silviana","Goffredo, Martina","Padoan, Rita","Badolato, Raffaele","32303430"],"journal":"J Cyst Fibros","authors":["Poli, Piercarlo","Timpano, Silviana","Goffredo, Martina","Padoan, Rita","Badolato, Raffaele"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303430","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jcf.2020.03.017","topics":["Case Report"],"weight":1,"_version_":1666138491089584128,"score":45.9185},{"pmid":32289235,"title":"Improved Prognosis in Cystic Fibrosis: Consideration for Intensive Care During the COVID-19 Pandemic.","text":["Improved Prognosis in Cystic Fibrosis: Consideration for Intensive Care During the COVID-19 Pandemic.","Am J Respir Crit Care Med","Ramos, Kathleen J","Pilewski, Joseph M","Faro, Albert","Marshall, Bruce C","32289235"],"journal":"Am J Respir Crit Care Med","authors":["Ramos, Kathleen J","Pilewski, Joseph M","Faro, Albert","Marshall, Bruce C"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32289235","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1164/rccm.202004-0999LE","keywords":["covid-19","cystic fibrosis","intensive care","prognosis","triage"],"topics":["Prevention"],"weight":1,"_version_":1666138491342290944,"score":43.503975},{"pmid":32406081,"title":"Air care: an 'aerography' of breath, buildings and bugs in the cystic fibrosis clinic.","text":["Air care: an 'aerography' of breath, buildings and bugs in the cystic fibrosis clinic.","With significant relevance to the Covid-19 pandemic, this paper contributes to emerging 'aerographic' research on the socio-materialities of air and breath, based on an in-depth empirical study of three hospital-based lung infection clinics treating people with cystic fibrosis. We begin by outlining the changing place of atmosphere in hospital design from the pre-antibiotic period and into the present. We then turn to the first of three aerographic themes where air becomes a matter of grasping and visualising otherwise invisible airborne infections. This includes imagining patients located within bodily spheres or 'cloud bodies', conceptually anchored in Irigaray's thoughts on the 'forgetting of the air' and Sloterdijk's immunitary 'spherology' of the body. Our second theme explores the material politics of air, air conditioning, window design and the way competing 'air regimes' come into conflict with each other at the interface of buildings, bodies and the biotic. Our final theme attends to the 'cost of air', the aero-economic problem of atmospheric scarcity within modern high-rise, deep-density healthcare architectures.","Sociol Health Illn","Brown, Nik","Buse, Chrissy","Lewis, Alan","Martin, Daryl","Nettleton, Sarah","32406081"],"abstract":["With significant relevance to the Covid-19 pandemic, this paper contributes to emerging 'aerographic' research on the socio-materialities of air and breath, based on an in-depth empirical study of three hospital-based lung infection clinics treating people with cystic fibrosis. We begin by outlining the changing place of atmosphere in hospital design from the pre-antibiotic period and into the present. We then turn to the first of three aerographic themes where air becomes a matter of grasping and visualising otherwise invisible airborne infections. This includes imagining patients located within bodily spheres or 'cloud bodies', conceptually anchored in Irigaray's thoughts on the 'forgetting of the air' and Sloterdijk's immunitary 'spherology' of the body. Our second theme explores the material politics of air, air conditioning, window design and the way competing 'air regimes' come into conflict with each other at the interface of buildings, bodies and the biotic. Our final theme attends to the 'cost of air', the aero-economic problem of atmospheric scarcity within modern high-rise, deep-density healthcare architectures."],"journal":"Sociol Health Illn","authors":["Brown, Nik","Buse, Chrissy","Lewis, Alan","Martin, Daryl","Nettleton, Sarah"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32406081","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/1467-9566.13104","keywords":["aerography","antimicrobial resistance (amr)","cystic fibrosis","lung infections","transmission","ventilation"],"weight":0,"_version_":1666802845635051521,"score":43.503975}]}